Effect of oral CDP-choline on plasma choline and uridine levels in humans.
about
Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbilsNeuroprotective properties of citicoline: facts, doubts and unresolved issuesChronic Uridine Administration Induces Fatty Liver and Pre-Diabetic Conditions in MiceA nutrient combination that can affect synapse formationProtective effects of citicoline on TNBS-induced experimental colitis in ratsNeurochemical alterations in methamphetamine-dependent patients treated with cytidine-5'-diphosphate choline: a longitudinal proton magnetic resonance spectroscopy study.CDP-choline increases plasma ACTH and potentiates the stimulated release of GH, TSH and LH: the cholinergic involvement.Pharmacodynamics of citicoline relevant to the treatment of glaucoma.Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: a 31-phosphorus magnetic resonance spectroscopy study at 4T.Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.Open-label uridine for treatment of depressed adolescents with bipolar disorderCiticoline mechanisms and clinical efficacy in cerebral ischemia.The relation of dietary choline to cognitive performance and white-matter hyperintensity in the Framingham Offspring CohortCytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disordersBacterial inhibition of phosphatidylcholine synthesis triggers apoptosis in the brain.Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses.Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents.Targeting alpha-7 nicotinic neurotransmission in schizophrenia: a novel agonist strategy.Human pyrimidine nucleotide biosynthesis as a target for antiviral chemotherapy.Radioprotective effect of transferrin targeted citicoline liposomes.Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice.Single- and repeated-dose oral toxicity studies of citicoline free-base (choline cytidine 5'-pyrophosphate) in Sprague-Dawley rats.Citicoline in stroke and TBI clinical trials.Centrally injected CDP-choline increases plasma vasopressin levels by central cholinergic activation.Declines in serum free and bound choline concentrations in humans after three different types of major surgery.Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations.Intraperitoneal administration of CDP-choline and its cholinergic and pyrimidinergic metabolites induce hyperglycemia in rats: involvement of the sympathoadrenal system.Scientific Opinion on the safety of “citicoline” as a Novel Food ingredientAcetylcholine precursor, citicoline (cytidine 5'-diphosphocholine), reduces hypoglycaemia-induced neuronal death in rats.Intraperitoneal administration of CDP-choline or a combination of cytidine plus choline improves nerve regeneration and functional recovery in a rat model of sciatic nerve injury.Elevation of serum cerebral injury markers correlates with serum choline decline after coronary artery bypass grafting surgery.Synaptogenesis: Modulation by Availability of Membrane Phospholipid Precursors.Uridine protects against hypoxic-ischemic brain injury by reducing histone deacetylase activity in neonatal rats.
P2860
Q24670540-A4DAAE9A-7955-4C9A-BD8A-3136FE3723A5Q27021189-DF6DC78E-0A19-4B1E-B275-008284956423Q28552696-7BB0F8DA-F0AA-49E8-AF50-90429DC84CCDQ33570506-2A385FD5-05DC-4E20-A025-BEB5CDA93373Q33756287-6EF0ED46-0C59-4AA2-9CDA-642751363318Q33979126-C48A2C6F-1306-4206-B619-97412E20587BQ34358553-B94EA14C-8804-417F-B6A5-BD323FFCEF21Q34488157-F354F04D-2BF7-417E-857A-4AB2D287A112Q34488173-BD78076F-E8D3-455B-9231-B30EB22C3FC3Q34711683-28A538C0-687B-4226-8604-967F9EABA0DCQ34831781-4F6DE963-FD58-4F95-877C-22184A430BAAQ34884148-3EA4F486-EE65-493A-835E-CDBAD9C46629Q35656447-19B51EB1-E58C-4CB3-9CFF-24D1F1810B9BQ35915801-0A50C5D1-EBBE-4084-9543-5BAC21192FC3Q36403935-9AA26C32-9EFD-40AD-9882-E290F944DA54Q36591904-3A906E5E-03F8-4EFA-9C12-DB017573234AQ36962755-9C1AC75D-3DE8-4250-A532-F27B96EB1044Q37067455-04E58855-C575-4E6B-A114-FC5E77085FF3Q39273755-23850BFA-685F-4717-8A39-436844561C7BQ40294416-51A8EA67-E1F3-4DD3-8FC4-532585795B18Q42664780-831B6645-AC00-45A6-8818-D819DF02AD75Q43228733-391C6B3F-0011-463F-A001-37D263A6BCEFQ44358646-7F721934-6D1E-4957-BE63-62ED242B0F22Q44746022-E594936B-5747-4A01-8663-4711F0DB066EQ45171326-D83D9A7E-6608-4D7B-9DD3-67AF77C46D00Q46766455-489CE0F5-244D-4EFD-A48E-A58A393397CEQ46965171-98DB81BD-EF28-4D5E-A554-2D0F41FDB75BQ47153833-E7AA3B97-873C-40F2-A877-F38EF85A96CBQ47912864-ACB02A7C-5580-4D76-847C-5653FBC8015AQ47980962-BC617C0A-61FF-43BC-A336-2229EFA72312Q48591346-A528AEC1-7B18-4260-89FB-542A29FFF7A2Q48702147-BB36557C-7144-4818-B3B3-AFCE4DD3187EQ52148797-751AF591-B7AC-4C58-AA77-F1AA98336AC8
P2860
Effect of oral CDP-choline on plasma choline and uridine levels in humans.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Effect of oral CDP-choline on plasma choline and uridine levels in humans.
@ast
Effect of oral CDP-choline on plasma choline and uridine levels in humans.
@en
type
label
Effect of oral CDP-choline on plasma choline and uridine levels in humans.
@ast
Effect of oral CDP-choline on plasma choline and uridine levels in humans.
@en
prefLabel
Effect of oral CDP-choline on plasma choline and uridine levels in humans.
@ast
Effect of oral CDP-choline on plasma choline and uridine levels in humans.
@en
P2093
P1476
Effect of oral CDP-choline on plasma choline and uridine levels in humans.
@en
P2093
P304
P356
10.1016/S0006-2952(00)00436-6
P407
P577
2000-10-01T00:00:00Z